Fluid Overload and Deresuscitation Practices in Michigan ICUS
Document Type
Conference Proceeding
Publication Date
10-2024
Publication Title
Chest
Abstract
PURPOSE: While fluid resuscitation is a core component of sepsis management, fluid overload has been associated with increased mortality. Estimates of the incidence of fluid overload in sepsis vary and are largely based on single-center studies. Furthermore, approaches to de-resuscitation—active fluid removal with dialysis and/or diuretics—are not well-studied. We sought to understand incidence of fluid overload and variation in de-resuscitation practices in ICU patients with sepsis across Michigan hospitals. METHODS: Retrospective cohort study of patients hospitalized with community-acquired sepsis from 12/2021-12/2023 at 66 hospitals in the Michigan Hospital Medicine Safety Consortium (HMS), a Collaborative Quality Initiative sponsored by Blue Cross Blue Shield of Michigan. The HMS-Sepsis registry includes a random sample of adult sepsis hospitalizations. Data are abstracted by professional abstractors at each site. Data for this period became available 3/2024. We included patients in the HMSSepsis registry who presented to the ED with sepsis-induced hypoperfusion (on vasopressors, SBP <90, MAP <65, or lactate $4 mmol/L within 3 hours), were admitted to the ICU for >24 hours, survived, and were discharged to the floor. Patients were excluded if no weights were documented on admission and ICU-to-floor transfer (last day ICU - floor day 2). Fluid overload was defined by weight gain from admission to ICU-to-floor transfer: <5% weight gain (no overload), 5-10% weight gain (mild overload), >10% weight gain (severe overload). De-resuscitation was defined as receiving renal replacement therapy (RRT) and/or diuretics on the day of ICU-to-floor transfer. We also assessed documentation of volume status at time of ICU-to-floor transfer based on abstractor chart review. Rates of de-resuscitation and documentation were compared using Chi-squared tests. Hospitals with <10 observations were dropped from analyses of hospital variation. RESULTS: Of 26,932 patients in the HMS-Sepsis registry, 1,545 (5.7%) met inclusion criteria. Of these, 941 (60.9%) had no overload, 286 (18.5%) had mild overload, and 318 (20.6%) had severe overload at ICU-to-floor transfer. Rates of fluid overload (combined mild and severe) ranged from 14.3% to 63.2% across hospitals. The proportion of patients receiving de-resuscitation (RRT and/or diuretics) at ICU-to-floor transfer was similar across volume status groups (no overload: 25.7%, mild overload: 25.5%, severe overload: 24.5%, p=0.69). Use of de-resuscitation varied across hospitals, with 0.0% to 50.0% of all patients receiving RRT and/or diuretics at ICU-to-floor transfer. Volume status documentation at ICU-to-floor transfer was also similar regardless of volume status group (no overload: 31.6%, mild overload: 29.7%, severe overload: 25.8%, p=0.15), though volume status was documented more often in patients receiving de-resuscitation (45.0% vs 24.9%, p<0.001). CONCLUSIONS: Over one-third of patients with sepsis-induced hypoperfusion were fluid overloaded at ICU discharge. However, rates of fluid overload and de-resuscitation varied widely across hospitals, and volume status did not correlate with deresuscitation or documentation. CLINICAL IMPLICATIONS: Our findings raise concern that fluid overload may be under-recognized, though our study is limited by potential errors in weights. Existing measures of fluid overload (weight, fluid balance) are subject to documentation error, which remains a major challenge to quantifying fluid overload. More work is needed to identify fluid overload and understand factors driving overload and approaches to de-resuscitation.
Volume
166
Issue
4 Suppl
First Page
A6379
Last Page
A6380
Recommended Citation
Munroe E, Weinstein J, Bozyk P, Cahill M, Digiovine B, Esteitie R, et al. Fluid overload and deresuscitation practices in Michigan ICUs. Chest. 2024 Oct;166(4 Suppl):A6379-A6380. doi: 10.1016/j.chest.2024.07.021
DOI
10.1016/j.chest.2024.07.021
Comments
Chest 2024 Annual Meeting, October 6-9, 2024, Boston, MA